Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1997 Apr 1;323(Pt 1):33–37. doi: 10.1042/bj3230033

Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor.

J Franssen 1, I Salemink 1, G M Willems 1, T C Wun 1, H C Hemker 1, T Lindhout 1
PMCID: PMC1218311  PMID: 9173898

Abstract

The inhibition of prothrombinase by tissue factor pathway inhibitor (TFPI) has been studied in the presence and absence of prothrombin. The rate constant of association of prothrombinase with full-length TFPI was 2.1x10(7) M-1.s-1 and 0.05x10(7) M-1.s-1 for the reaction with C-terminus truncated TFPI (TFPI1-161). The rate constant of dissociation was 0.65x10(-4) s-1 in both cases. The rate constant of inhibition of prothrombinase by TFPI1-161 was similar to that of solution-phase factor Xa. In contrast, phospholipids and factor Va enhanced the association rate of the reaction between factor Xa and full-length TFPI by approx. 20-fold. Although TFPI, and in particular the full-length variant of the molecule, is a potent inhibitor of prothrombinase (overall inhibition constant of 3 pM), we also found that prothrombin competed very effectively with TFPI for the active site of factor Xa in the prothrombinase complex. A 50% reduction of the rate constant of inhibition was measured in the presence of 4 nM prothrombin, i.e. 0.2% of the plasma concentration of prothrombin. The physiological significance of TFPI as an inhibitor of prothrombinase activity is thus questionable.

Full Text

The Full Text of this article is available as a PDF (292.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Billy D., Speijer H., Lindhout T., Hemker H. C., Willems G. M. Inhibition of prothrombinase at macroscopic lipid membranes: competition between antithrombin and prothrombin. Biochemistry. 1995 Oct 17;34(41):13699–13704. doi: 10.1021/bi00041a052. [DOI] [PubMed] [Google Scholar]
  2. Billy D., Speijer H., Willems G., Hemker H. C., Lindhout T. Prothrombin activation by prothrombinase in a tubular flow reactor. J Biol Chem. 1995 Jan 20;270(3):1029–1034. doi: 10.1074/jbc.270.3.1029. [DOI] [PubMed] [Google Scholar]
  3. Chase T., Jr, Shaw E. Comparison of the esterase activities of trypsin, plasmin, and thrombin on guanidinobenzoate esters. Titration of the enzymes. Biochemistry. 1969 May;8(5):2212–2224. doi: 10.1021/bi00833a063. [DOI] [PubMed] [Google Scholar]
  4. Ellis V., Scully M. F., Kakkar V. V. The acceleration of the inhibition of platelet prothrombinase complex by heparin. Biochem J. 1986 Jan 1;233(1):161–165. doi: 10.1042/bj2330161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Govers-Riemslag J. W., Janssen M. P., Zwaal R. F., Rosing J. Effect of membrane fluidity and fatty acid composition on the prothrombin-converting activity of phospholipid vesicles. Biochemistry. 1992 Oct 20;31(41):10000–10008. doi: 10.1021/bi00156a020. [DOI] [PubMed] [Google Scholar]
  6. Hendrix H., Lindhout T., Mertens K., Engels W., Hemker H. C. Activation of human prothrombin by stoichiometric levels of staphylocoagulase. J Biol Chem. 1983 Mar 25;258(6):3637–3644. [PubMed] [Google Scholar]
  7. Huang Z. F., Wun T. C., Broze G. J., Jr Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem. 1993 Dec 25;268(36):26950–26955. [PubMed] [Google Scholar]
  8. Jesty J., Wun T. C., Lorenz A. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin. Biochemistry. 1994 Oct 25;33(42):12686–12694. doi: 10.1021/bi00208a020. [DOI] [PubMed] [Google Scholar]
  9. Krishnaswamy S., Vlasuk G. P., Bergum P. W. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide. Biochemistry. 1994 Jun 28;33(25):7897–7907. doi: 10.1021/bi00191a017. [DOI] [PubMed] [Google Scholar]
  10. Lindhout M. J., Kop-Klaassen B. H., Hemker H. C. Activation of decarboxyfactor X by a protein from Russell's viper venom. Purification and partial characterization of activated decarboxyfactor X. Biochim Biophys Acta. 1978 Apr 26;533(2):327–341. doi: 10.1016/0005-2795(78)90379-3. [DOI] [PubMed] [Google Scholar]
  11. Lindhout T., Baruch D., Schoen P., Franssen J., Hemker H. C. Thrombin generation and inactivation in the presence of antithrombin III and heparin. Biochemistry. 1986 Oct 7;25(20):5962–5969. doi: 10.1021/bi00368a019. [DOI] [PubMed] [Google Scholar]
  12. Lindhout T., Franssen J., Willems G. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor. Thromb Haemost. 1995 Sep;74(3):910–915. [PubMed] [Google Scholar]
  13. Lindhout T., Govers-Riemslag J. W., van de Waart P., Hemker H. C., Rosing J. Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition. Biochemistry. 1982 Oct 26;21(22):5494–5502. doi: 10.1021/bi00265a018. [DOI] [PubMed] [Google Scholar]
  14. Lindhout T., Willems G., Blezer R., Hemker H. C. Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor. Biochem J. 1994 Jan 1;297(Pt 1):131–136. doi: 10.1042/bj2970131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Marciniak E. Factor-Xa inactivation by antithrombin. 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complex. Br J Haematol. 1973 Mar;24(3):391–400. doi: 10.1111/j.1365-2141.1973.tb01662.x. [DOI] [PubMed] [Google Scholar]
  16. Mast A. E., Broze G. J., Jr Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood. 1996 Mar 1;87(5):1845–1850. [PubMed] [Google Scholar]
  17. Mertens K., Bertina R. M. Pathways in the activation of human coagulation factor X. Biochem J. 1980 Mar 1;185(3):647–658. doi: 10.1042/bj1850647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nesheim M. E., Taswell J. B., Mann K. G. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J Biol Chem. 1979 Nov 10;254(21):10952–10962. [PubMed] [Google Scholar]
  19. Rosing J., Tans G., Govers-Riemslag J. W., Zwaal R. F., Hemker H. C. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem. 1980 Jan 10;255(1):274–283. [PubMed] [Google Scholar]
  20. Schoen P., Lindhout T., Willems G., Hemker H. C. Antithrombin III-dependent anti-prothrombinase activity of heparin and heparin fragments. J Biol Chem. 1989 Jun 15;264(17):10002–10007. [PubMed] [Google Scholar]
  21. Smith R. L. Titration of activated bovine Factor X. J Biol Chem. 1973 Apr 10;248(7):2418–2423. [PubMed] [Google Scholar]
  22. Speijer H., Billy D., Willems G., Hemker H. C., Lindhout T. Inhibition of prothrombinase by antithrombin-heparin at a macroscopic surface. Thromb Haemost. 1995 Apr;73(4):648–653. [PubMed] [Google Scholar]
  23. Teitel J. M., Rosenberg R. D. Protection of factor Xa from neutralization by the heparin-antithrombin complex. J Clin Invest. 1983 May;71(5):1383–1391. doi: 10.1172/JCI110891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Valentin S., Schousboe I. Factor Xa enhances the binding of tissue factor pathway inhibitor to acidic phospholipids. Thromb Haemost. 1996 May;75(5):796–800. [PubMed] [Google Scholar]
  25. Willems G. M., Giesen P. L., Hermens W. T. Adsorption and conversion of prothrombin on a rotating disc. Blood. 1993 Jul 15;82(2):497–504. [PubMed] [Google Scholar]
  26. Wun T. C., Kretzmer K. K., Girard T. J., Miletich J. P., Broze G. J., Jr Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem. 1988 May 5;263(13):6001–6004. [PubMed] [Google Scholar]
  27. van Rijn J. L., Govers-Riemslag J. W., Zwaal R. F., Rosing J. Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex. Biochemistry. 1984 Sep 25;23(20):4557–4564. doi: 10.1021/bi00315a008. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES